This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Buy Low-Beta Stocks JD, SKWD, CORT, PRA to Beat Election Uncertainty
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. JD, SKWD, CORT & PRA are well-poised to gain.
Is AMERISAFE Stock a Pricey Pick or a Hidden Gem for Your Portfolio?
by Zacks Equity Research
Uncertainty surrounds the stock due to AMSF's continuous decline in net premiums earned over the past several years.
ProAssurance Jumps 33% in 3 Months: Is it Still a Good Bet for You?
by Zacks Equity Research
Appealing valuation, upward trend in earnings estimates and rising investment income bode well for PRA.
Zacks.com featured highlights include The Progressive, JD.com, Mission Produce and ProAssurance
by Zacks Equity Research
The Progressive, JD.com, Mission Produce and ProAssurance have been highlighted in this Screen of The Week article.
Secure Your Portfolio With 4 Low-Beta Stocks: PGR, JD, AVO, PRA
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. PGR, JD, AVO & PRA are well-poised to gain.
ProAssurance (PRA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Bull of the Day: Axis Capital Holdings (AXS)
by Shaun Pruitt
Axis Capital Holdings' (AXS) stock stands out among the top-rated Zacks Insurance-Property and Casualty Industry
W. R. Berkley Stock Up 14% in 3 Months: Will the Rally Last?
by Zacks Equity Research
WRB is set to grow on solid insurance business, momentum in international business and a sturdy financial position.
Time to Buy These Top Insurance Stocks Amid Heightened Market Volatility
by Shaun Pruitt
Amid heightened market volatility investors may want to consider several insurance stocks that have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.
Wall Street Analysts See a 25% Upside in ProAssurance (PRA): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 25% upside potential for ProAssurance (PRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
AXIS Capital Rallies 38% YTD: Can the Stock Retain the Momentum?
by Zacks Equity Research
AXS continues to build on specialty insurance, reinsurance as well as its accident and health portfolio.
First American (FAF) Rises 15% in 6 Months: Will the Rally Last?
by Zacks Equity Research
First American (FAF) remains well-poised to capitalize on the increased demand for first-time home purchases among millennials.
Chubb (CB) Rallies 37% in a Year: More Room for Upside?
by Zacks Equity Research
Chubb (CB) is set to grow on a compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and a solid capital position.
NMI Holdings (NMIH) Surges 29% YTD: Will the Rally Last?
by Zacks Equity Research
NMI Holdings (NMIH) is set to grow on an improving mortgage insurance portfolio, higher new insurance written volume, a comprehensive reinsurance program and its solid capital position.
Arch Capital (ACGL) Rallies 32% YTD: More Room for Growth?
by Zacks Equity Research
Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position.
Earnings Estimates Rising for ProAssurance (PRA): Will It Gain?
by Zacks Equity Research
ProAssurance (PRA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think ProAssurance (PRA) Could Surge 27.67%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.7% in ProAssurance (PRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ProAssurance (PRA) Q2 Earnings Beat, Surge Y/Y on Lower Costs
by Zacks Equity Research
ProAssurance's (PRA) Q2 results reflect strong underwriting results in the Specialty P&C segment and investment income growth, despite profitability pressures in some segments.
ProAssurance (PRA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for ProAssurance (PRA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ProAssurance (PRA) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 187.50% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Root, Inc. (ROOT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Root (ROOT) delivered earnings and revenue surprises of 70.11% and 25.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ProAssurance (PRA) Q2 Earnings: Profit Climb or Slippery Slope?
by Zacks Equity Research
ProAssurance's (PRA) second-quarter results are likely to reflect growing investment income.
ProAssurance (PRA) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for ProAssurance (PRA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Heritage Insurance (HRTG) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Heritage Insurance (HRTG) delivered earnings and revenue surprises of 60.53% and 3.44%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Upbound Group (UPBD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Upbound Group (UPBD) delivered earnings and revenue surprises of 1.96% and 3.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?